Straumann Holding AG
Straumann posts 26% rise in nine-month sales to CHF 314 million
Corporate-news announcement processed and sent by DGAP.
The sender is solely responsible for the contents of this announcement.
——————————————————————————–
Straumann posts 26% rise in nine-month sales to CHF 314 million
In the first nine months of 2004, Straumann’s Group sales climbed 27% in
local currencies (l.c.), or 26% in Swiss francs, to CHF 314 million. Sales
growth continued to be driven by volume increases, which contributed 21%
points, while price increases added one further percentage point. With the
growth effect from the Biora acquisition discontinuing at the end of June,
just 4% points of sales growth over nine months were acquisition related.
The effect of currency translations amounted to 1% point, as the positive
effect of the Euro only partially offset the negative impact of the US
dollar.
Please find the complete media release as PDF below:
http://www.newsbox.ch/public/1746/att/1576_mediarelease.pdf
Waldenburg, 21 October 2004
Contacts:
Gilbert Achermann,
Chief Executive Officer
(+41) 061 965 1111
or
Martin Gertsch,
Chief Financial Officer
(+41) 061 965 1111
About Straumann
Headquartered in Waldenburg, Switzerland, Straumann is a global leader in
oral implantology and tissue regeneration. In collaboration with the
International Team for Implantology (ITI), leading clinics, research
institutes and universities, the Group researches, develops, produces and
distributes implants, instruments and tissue regeneration products for use
in tooth replacement solutions or to prevent tooth loss. Straumann also
provides training and services to the dental profession worldwide.
Straumann’s implants and instruments are manufactured in Switzerland, whilst
its dental tissue regeneration products are produced in Sweden. With
affiliates in 14 countries and distributors in 35, Straumann employs more
than 1000 people worldwide. In 2003, the Group generated sales of CHF 344
million and a net income of CHF 80 million.
Straumann Holding AG, Hauptstrasse 26, 4437 Waldenburg, Switzerland
Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01
e-mail: investor.relations@straumann.com or info@straumann.com
Homepage: http://www.straumann.com
end of message, (c)DGAP 21.10.2004
——————————————————————————–
WKN: 914326; ISIN: CH0012280076; Index:
Listed: Freiverkehr in Berlin-Bremen, Frankfurt, München und Stuttgart; SWX
Swiss Exchange
210747 Okt 04
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden